Roger Sawhney
Chief Financial Officer, Omega Therapeutics, Inc.
Companies
- Adlai Nortye Group Ltd.Board member Jul 15, 2026 to now1
- Arbutus BiopharmaBoard member Aug 6, 2025 to now2
- ACTUATE THERAPEUTICS, INC.Board member Aug 14, 2024 to now3
- Alimera SciencesBoard member Mar 1, 2023 to Mar 1, 20234
- Omega Therapeutics, Inc.Chief financial officer Jul 29, 2021 to Mar 11, 20225
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Arbutus Biopharma ABUS30,825 shares6$132.1K at $4.29Sep 18, 2026- Adlai Nortye Group Ltd. ANL9,838 shares7$110.5K at $11.23Jul 15, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 18, 2026Shares withheld for tax 100,508 shares at $5.07 of Arbutus Biopharma6
- Sep 18, 2026Exercised options 78,800 shares at $4.24 of Arbutus Biopharma6
- Sep 18, 2026Exercised options 52,533 shares at $3.34 of Arbutus Biopharma6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARArbutus Biopharma, Board member
- 3
- 4SEC EDGARAlimera Sciences, Board member
- 5
- 6
- 7